ClearPoint Neuro (CLPT) Operating Income (2011 - 2026)

ClearPoint Neuro has disclosed Operating Income across 15 years of filings, most recently posting -$10.2 million for Q2 2026.

• In Q2 2026, Operating Income fell 80.35% year-over-year to -$10.2 million; the TTM figure through Jun 2026 stood at -$31.0 million (down 37.13% YoY), while the FY2025 annual figure was -$24.2 million, down 22.45% from the prior year.
• Operating Income came in at -$10.2 million for Q2 2026 at ClearPoint Neuro, down from -$8.5 million in the prior quarter.
• In the past five years, Operating Income ranged from a high of -$3.8 million in Q3 2022 to a low of -$10.2 million in Q2 2026.
• Average Operating Income over 5 years is -$5.6 million, with a median of -$5.2 million recorded in 2024.
• Year-over-year, Operating Income jumped 33.75% in 2024 and slumped 80.35% in 2026.
• Over 5 years, Operating Income stood at -$4.5 million in 2022, then retreated by 5.3% to -$4.7 million in 2023, then fell by 19.76% to -$5.6 million in 2024, then declined by 25.0% to -$7.0 million in 2025, then sank by 45.41% to -$10.2 million in 2026.
• Per Business Quant data, the three most recent Operating Income figures were -$10.2 million in Q2 2026, -$8.5 million in Q1 2026, and -$7.0 million in Q4 2025.